Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
14.05. | UnitedHealth CEO Chris Witty steps down | ||
13.05. | Digital support reduces GLP-1 dose needed for weight loss | ||
13.05. | Bayer CEO confident firm can cope with Xarelto hit | ||
13.05. | Galapagos drops plan to split after 'market developments' | ||
13.05. | Azafaros bags €132m for rare neuro-metabolic disorder drugs | ||
13.05. | Novo Nordisk builds case for Norditropin successor | ||
12.05. | Digital therapy for Tourette syndrome backed for NHS use | ||
12.05. | UK approves AZ inhaler with 'greener' propellant | ||
12.05. | Could an AI for biological age guide cancer treatment? | ||
12.05. | More data backs Zepbound over Wegovy for weight loss | ||
12.05. | More data back Zepbound over Wegovy for weight loss | ||
12.05. | Trump says he will tie US drug prices to other countries | ||
09.05. | Vor Bio winding down as multiple biotechs downsize | ||
09.05. | GSK reveals data behind linerixibat for PBC 'relentless itch' | ||
09.05. | AZ plots wider Imfinzi use in bladder cancer after trial win | ||
09.05. | Pharma still in waiting mode after UK-US trade agreement | ||
08.05. | FDA announces generative AI pilot and rapid rollout plans | ||
08.05. | Boehringer advances oral therapy for geographic atrophy | ||
08.05. | Gilead ups its US investment plans by $11 billion | ||
08.05. | Spectre of 'favoured nation' pricing manifests again in US | ||
08.05. | Shionogi aims to buy tobacco giant's pharma unit for $1bn | ||
08.05. | RFK Jr launches database project to explore autism causes | ||
07.05. | New data could move Enhertu into early breast cancer | ||
07.05. | UK trumpets a trade deal with India - but pharma isn't happy | ||
07.05. | AI trained on NHS data 'may predict ill health in advance' |